Axial3D Secures USD 18.2 Million to Accelerate AI-Driven 3D Medical Imaging Technology

The latest funding round, led by 57 Stars and supported by strategic investors, will fuel Axial3D’s mission to revolutionize patient-specific surgery globally.

Axial3D, a leader in AI-powered 3D medical imaging, has raised USD 18.2 million in a recent investment round to expand its groundbreaking technology. This new funding includes continued support from previous investors such as Techstart, Innovation Ulster Limited, and business angels from both the US and Northern Ireland. Notably, 57 Stars has made a USD 10 million investment, making it the company’s largest shareholder.

Roger Johnston, CEO of Axial3D, expressed his excitement about the investment, which will drive the company's mission to make patient-specific surgeries a global standard. “Our market-fundamental patented technology platform empowers medical device companies, medical imaging companies, and hospitals to standardize the use of incredibly precise, patient-specific 3D data,” said Johnston. He emphasized that the company’s AI technology is set to impact millions of patients, improving applications in robotics, planning, and patient-specific workflows.

The new investors are confident in Axial3D’s potential to lead the transformation of personalized healthcare. Bernie McGuire, Managing Director of 57 Stars, lauded the company’s pioneering role in Medtech, citing its ability to create scalable patient-specific solutions. Neil McCabe, Director of Whiterock, added that Axial3D’s technology addresses a crucial healthcare need, enabling more accessible and precise surgical solutions globally.

With this fresh injection of capital, Axial3D is poised to drive advancements in personalized care, reshaping the future of surgery and healthcare worldwide.